数据中心
龙虎榜
大单追踪
资金流向
业绩预告
新股申购
行情中心
沪深市场
香港市场
美国市场
全球市场
行业风云
全球市场
向上 向下

董事介绍

注:董事持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Thomas F. Frist III Chairman 56 40.28万美元 1.22 2024-05-01
Samuel N. Hazen Chief Executive Officer and Director 65 1463.77万美元 205.85 2024-05-01
Andrea B. Smith Director 56 35.74万美元 0.30 2024-05-01
Meg G. Crofton Director 70 31.99万美元 0.57 2024-05-01
Michael W. Michelson Director 73 34.67万美元 0.94 2024-05-01
Wayne J. Riley Director 64 34.99万美元 1.33 2024-05-01
Robert J. Dennis Director 70 34.49万美元 2.46 2024-05-01
Hugh F. Johnston Director 62 33.24万美元 0.20 2024-05-01
William R. Frist Director 55 30.98万美元 41.66 2024-05-01
Nancy Ann M. DeParle Director 67 33.49万美元 2.01 2024-05-01

高管介绍

注:高管持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Samuel N. Hazen Chief Executive Officer and Director 65 1463.77万美元 205.85 2024-05-01
Michael S. Cuffe Executive Vice President and Chief Clinical Officer 58 515.79万美元 未持股 2024-05-01
Kathryn A. Torres Senior Vice President — Payer Contracting and Alignment 60 未披露 未持股 2024-05-01
Christopher F. Wyatt Senior Vice President and Controller 46 未披露 未持股 2024-05-01
Phillip G. Billington Senior Vice President — Internal Audit Services 56 未披露 未持股 2024-05-01
Deborah M. Reiner Senior Vice President — Marketing and Communications 62 未披露 未持股 2024-05-01
Kathleen M. Whalen Senior Vice President and Chief Ethics and Compliance Officer 60 未披露 未持股 2024-05-01
Jennifer L. Berres Senior Vice President and Chief Human Resources Officer 53 未披露 未持股 2024-05-01
Jeff E. Cohen Senior Vice President — Government Relations 52 未披露 未持股 2024-05-01
Michael R. McAlevey Executive Vice President – Chief Legal and Administrative Officer 60 646.56万美元 未持股 2024-05-01
Sammie S. Mosier -- Senior Vice President and Chief Nurse Executive 49 未披露 未持股 2024-05-01
Erol R. Akdamar President — American Group 56 未披露 24.92 2024-05-01
Michael A. Marks Senior Vice President — Finance 54 未披露 未持股 2024-05-01
Richard A. Hammett President — Atlantic Group 54 未披露 未持股 2024-05-01
Timothy M. McManus President — National Group 52 未披露 12.00 2024-05-01
Charles J. Hall President — National Group 72 499.61万美元 未持股 2024-05-01
Joseph A. Sowell, III Senior Vice President and Chief Development Officer 69 未披露 未持股 2024-05-01
Jon M. Foster Executive Vice President and Chief Operating Officer 62 414.82万美元 32.78 2024-05-01
P. Martin Paslick Senior Vice President and Chief Information Officer 64 未披露 未持股 2024-05-01

董事简历

中英对照 |  中文 |  英文
Thomas F. Frist III

Thomas F. Frist III,他曾一直担任董事(2015年12月以来)。他是Frist Capital, LLC(美国田纳西州纳什维尔的一个投资公司,并长期股权投资公共和私人公司)的创始人兼管理负责人(1994年以来)。他此前曾担任FS Partners, L.L.C.的管理成员,也曾担任Rainwater, Inc的首席投资官。他持有Princeton University的学士学位,以及Harvard Business School的工商管理硕士学位。


Thomas F. Frist III,has served as a director since December 2015. Since April 2019,Mr. Frist has served as Chairman of the Board of Directors of HCA Healthcare,Inc. where he has served as a director since 2006. Mr. Frist is the Founder and Managing Principal of Frist Capital,LLC,an investment firm based in Nashville,Tennessee he founded in 2002 that makes long-term equity investments in public and private companies. Prior to that he was the managing member of FS Partners II,LLC and he worked in principal investments at Rainwater,Inc. from 1992 to 1995. Mr. Frist previously served as a director of Science Applications International Corporation from 2013 until 2017. Mr. Frist holds a B.A. degree from Princeton University and an M.B.A. degree from Harvard Business School.Mr. Frist's significant directorship experience provides valuable expertise and perspective to the Board. His directorship experience includes having chaired,and served as a member of,various public company board committees. In addition to his significant experience as a public company director,Mr. Frist provides valuable experience in areas of business administration,finance,and operations,which the Board values.
Thomas F. Frist III,他曾一直担任董事(2015年12月以来)。他是Frist Capital, LLC(美国田纳西州纳什维尔的一个投资公司,并长期股权投资公共和私人公司)的创始人兼管理负责人(1994年以来)。他此前曾担任FS Partners, L.L.C.的管理成员,也曾担任Rainwater, Inc的首席投资官。他持有Princeton University的学士学位,以及Harvard Business School的工商管理硕士学位。
Thomas F. Frist III,has served as a director since December 2015. Since April 2019,Mr. Frist has served as Chairman of the Board of Directors of HCA Healthcare,Inc. where he has served as a director since 2006. Mr. Frist is the Founder and Managing Principal of Frist Capital,LLC,an investment firm based in Nashville,Tennessee he founded in 2002 that makes long-term equity investments in public and private companies. Prior to that he was the managing member of FS Partners II,LLC and he worked in principal investments at Rainwater,Inc. from 1992 to 1995. Mr. Frist previously served as a director of Science Applications International Corporation from 2013 until 2017. Mr. Frist holds a B.A. degree from Princeton University and an M.B.A. degree from Harvard Business School.Mr. Frist's significant directorship experience provides valuable expertise and perspective to the Board. His directorship experience includes having chaired,and served as a member of,various public company board committees. In addition to his significant experience as a public company director,Mr. Frist provides valuable experience in areas of business administration,finance,and operations,which the Board values.
Samuel N. Hazen

Samuel N. Hazen在2011年2月被任命为公司运营的总裁。他从2001年7月到2011年2月担任西方集团的总裁,从1995年8月到2001年7月担任公司西方集团的首席财务官。他从1994年2月到1995年7月担任公司北德克萨斯的首席财务官。在此之前,他在不同医院工作,在Humana Inc.和Galen Health Care, Inc.担任区域财务总监职位。


Samuel N. Hazen,has served as Chief Executive Officer since January 2019. From November 2016 through December 2018, Mr. Hazen served as the Company's President and Chief Operating Officer. Prior to that, he served as Chief Operating Officer of the Company from January 2015 to November 2016 and as President — Operations of the Company from 2011 to 2015. He also served as President — Western Group from 2001 to 2011 and as Chief Financial Officer — Western Group of the Company from 1995 to 2001. Prior to that time, Mr. Hazen served in various hospital, regional and division Chief Financial Officer positions with the Company, Humana Inc. and Galen Health Care, Inc.
Samuel N. Hazen在2011年2月被任命为公司运营的总裁。他从2001年7月到2011年2月担任西方集团的总裁,从1995年8月到2001年7月担任公司西方集团的首席财务官。他从1994年2月到1995年7月担任公司北德克萨斯的首席财务官。在此之前,他在不同医院工作,在Humana Inc.和Galen Health Care, Inc.担任区域财务总监职位。
Samuel N. Hazen,has served as Chief Executive Officer since January 2019. From November 2016 through December 2018, Mr. Hazen served as the Company's President and Chief Operating Officer. Prior to that, he served as Chief Operating Officer of the Company from January 2015 to November 2016 and as President — Operations of the Company from 2011 to 2015. He also served as President — Western Group from 2001 to 2011 and as Chief Financial Officer — Western Group of the Company from 1995 to 2001. Prior to that time, Mr. Hazen served in various hospital, regional and division Chief Financial Officer positions with the Company, Humana Inc. and Galen Health Care, Inc.
Andrea B. Smith

Andrea B. Smith,自2015年7月起担任首席行政官;2010年1月至2015年7月担任人力资源主管。


Andrea B. Smith,retired from Bank of America in December 2021 after nearly 34 years with the company. Most recently, she served as chief administrative officer from August 2015 through December 2021. Previously, she led Global Human Resources from January 2010 to August 2015. She also serves on the boards of several nonprofit organizations, including the PGA of America and the Charlotte Sports Foundation.
Andrea B. Smith,自2015年7月起担任首席行政官;2010年1月至2015年7月担任人力资源主管。
Andrea B. Smith,retired from Bank of America in December 2021 after nearly 34 years with the company. Most recently, she served as chief administrative officer from August 2015 through December 2021. Previously, she led Global Human Resources from January 2010 to August 2015. She also serves on the boards of several nonprofit organizations, including the PGA of America and the Charlotte Sports Foundation.
Meg G. Crofton

Meg G. Crofton在与华特迪斯尼公司共事35年后于2015年退休。2006年至2013年,她担任迪士尼乐园及度假村部门最大的站点华特迪士尼世界总裁,从2011年起至2015年退休,担任美国和法国迪士尼公园及度假村运营总裁。Crofton女士自2016年起担任Tupperware Brands Corporation的董事,2017年起担任Cracker Barle Old Country Store,Inc.的董事。自2019年3月以来,她担任HCA Healthcare, Inc.(“HCA”)的董事,任职HCA的薪酬委员会以及HCA的患者安全和护理质量委员会。


Meg G. Crofton,Retired President, Walt Disney Parks & Resorts Operations, U.S. & France of The Walt Disney Company, a diversified worldwide entertainment company, a position she held from 2011 to 2015. Ms. Crofton also served as President, Walt Disney World Resort, from 2006 to 2013, and previously in various positions of increasing responsibility for The Walt Disney Company since 1977. Ms. Crofton has extensive experience in diversified operations, staff and executive roles with a highly respected global brand, in addition to having served on boards of other public companies. Ms. Crofton holds an undergraduate degree in Marketing and an M.B.A. from Florida State University.
Meg G. Crofton在与华特迪斯尼公司共事35年后于2015年退休。2006年至2013年,她担任迪士尼乐园及度假村部门最大的站点华特迪士尼世界总裁,从2011年起至2015年退休,担任美国和法国迪士尼公园及度假村运营总裁。Crofton女士自2016年起担任Tupperware Brands Corporation的董事,2017年起担任Cracker Barle Old Country Store,Inc.的董事。自2019年3月以来,她担任HCA Healthcare, Inc.(“HCA”)的董事,任职HCA的薪酬委员会以及HCA的患者安全和护理质量委员会。
Meg G. Crofton,Retired President, Walt Disney Parks & Resorts Operations, U.S. & France of The Walt Disney Company, a diversified worldwide entertainment company, a position she held from 2011 to 2015. Ms. Crofton also served as President, Walt Disney World Resort, from 2006 to 2013, and previously in various positions of increasing responsibility for The Walt Disney Company since 1977. Ms. Crofton has extensive experience in diversified operations, staff and executive roles with a highly respected global brand, in addition to having served on boards of other public companies. Ms. Crofton holds an undergraduate degree in Marketing and an M.B.A. from Florida State University.
Michael W. Michelson

Michael W. Michelson,KKR管理有限责任公司高级顾问合伙人,私人股本投资管理公司及KKR有限公司普通合伙人,自2018年1月起至2020年1月退休。此前为KKR管理有限责任公司成员,2009年10月至今。在此之前,Michelson先生是有限责任公司的成员,自1996年以来一直担任Kohlberg Kravis Roberts & Co. L.P.的普通合伙人。1981年加入KKR。Michelson先生在KKR投资组合公司的发展中发挥了重要作用。他的职业生涯始于洛杉矶的Latham & Watkins律师事务所,在那里他参与了广泛的公司业务,同时专门从事管理层收购。他获得了哈佛大学的学士学位和哈佛法学院的法学博士学位。


Michael W. Michelson,was a Senior Advisory Partner of KKR & Co. L.P. from January 2018 to the end of 2019. From 2009 to 2018, he was a member of KKR Management LLC, a private equity investment manager and the general partner of KKR & Co. L.P. Before that, Mr. Michelson was a member of the limited liability company which served as the general partner of KKR & Co. L.P. from 1996 to 2009. Prior to that, he was a general partner of KKR & Co. L.P. Mr. Michelson previously served as a director of the Company from 2006 to 2016. He has been a director of Zimmer Biomet Holdings, Inc., a medical device company, since June 2015 and was previously a director of Biomet, Inc. from 2007 to 2015.
Michael W. Michelson,KKR管理有限责任公司高级顾问合伙人,私人股本投资管理公司及KKR有限公司普通合伙人,自2018年1月起至2020年1月退休。此前为KKR管理有限责任公司成员,2009年10月至今。在此之前,Michelson先生是有限责任公司的成员,自1996年以来一直担任Kohlberg Kravis Roberts & Co. L.P.的普通合伙人。1981年加入KKR。Michelson先生在KKR投资组合公司的发展中发挥了重要作用。他的职业生涯始于洛杉矶的Latham & Watkins律师事务所,在那里他参与了广泛的公司业务,同时专门从事管理层收购。他获得了哈佛大学的学士学位和哈佛法学院的法学博士学位。
Michael W. Michelson,was a Senior Advisory Partner of KKR & Co. L.P. from January 2018 to the end of 2019. From 2009 to 2018, he was a member of KKR Management LLC, a private equity investment manager and the general partner of KKR & Co. L.P. Before that, Mr. Michelson was a member of the limited liability company which served as the general partner of KKR & Co. L.P. from 1996 to 2009. Prior to that, he was a general partner of KKR & Co. L.P. Mr. Michelson previously served as a director of the Company from 2006 to 2016. He has been a director of Zimmer Biomet Holdings, Inc., a medical device company, since June 2015 and was previously a director of Biomet, Inc. from 2007 to 2015.
Wayne J. Riley

Wayne J. Riley, 他是范德堡大学(Vanderbilt University)医学院的临床医学教授和范德堡大学(Vanderbilt University)的欧文管理学院 (Owen Graduate School of Management)的医疗管理副教授。从2007年1月到2013年7月,他担任玛雅医学院(Meharry Medical College)的总裁和首席执行官。在玛雅医学院(Meharry Medical College)是,他担任内科医学终身教授并且是其罗伯特·伍德·约翰逊卫生政策中心(the Robert Wood Johnson Center for Health Policy )的高级卫生政策助理。从2004年5月到2006年12月,他担任公司官员和执行管理团队成员。他担任贝勒医学院(Baylor College of Medicine)的副总裁、卫生事务和政府关系副院长和医学副教授。他还担任Ben Taub General Hospital的首席医学助理。他是HCA Holdings, Inc.(美国医院公司(Hospital Corporation of American,医院和卫生设施的领导运营商)的母公司)的董事会成员。他是 Pinnacle Financial Partners的前董事和亚特兰大联邦储备银行(the Federal Reserve Bank of Atlanta)纳什维尔分行委员会前董事。他获得耶鲁大学(Yale University )的学士学位、杜兰大学(Tulane University)公共卫生与热带医学学院的健康系统管理硕士学位、莱斯大学(Rice University)琼斯管理研究生院(Jones Graduate School of Management)的工商管理硕士学位以及其豪斯医学院(the Morehouse School of Medicine)的硕士学位。


Wayne J. Riley,has served as president of SUNY Downstate Health Sciences University since April 2017, where he is also a tenured professor of internal medicine and health policy and management. From 2013 to 2017, he was Adjunct Professor of Healthcare Management, Owen Graduate School of Management, Vanderbilt University and Clinical Professor of Medicine, Vanderbilt University School of Medicine. From 2007 to 2013, he served as President and CEO of Meharry Medical College. From 2003 through 2006, Dr. Riley served as Vice-President and Vice Dean for Health Affairs and Governmental Relations, Baylor College of Medicine. Dr. Riley has also served as a director of Compass Pathways, plc since 2021 and HeartFlow, Inc. since 2021. Dr. Riley served as a director of Vertex Pharmaceuticals Incorporated from 2010 to 2015, Pinnacle Financial Partners, Inc. from 2007 to 2013 and the Federal Reserve Board of Atlanta, Nashville Branch from January 2013 to June 2013. He is President Emeritus of the American College of Physicians and an elected member of the National Academy of Medicine. Dr. Riley is also a Commissioner of the Medicare Payment Advisory Commission (MedPAC) and Chair of the Board of Trustees of The New York Academy of Medicine.
Wayne J. Riley, 他是范德堡大学(Vanderbilt University)医学院的临床医学教授和范德堡大学(Vanderbilt University)的欧文管理学院 (Owen Graduate School of Management)的医疗管理副教授。从2007年1月到2013年7月,他担任玛雅医学院(Meharry Medical College)的总裁和首席执行官。在玛雅医学院(Meharry Medical College)是,他担任内科医学终身教授并且是其罗伯特·伍德·约翰逊卫生政策中心(the Robert Wood Johnson Center for Health Policy )的高级卫生政策助理。从2004年5月到2006年12月,他担任公司官员和执行管理团队成员。他担任贝勒医学院(Baylor College of Medicine)的副总裁、卫生事务和政府关系副院长和医学副教授。他还担任Ben Taub General Hospital的首席医学助理。他是HCA Holdings, Inc.(美国医院公司(Hospital Corporation of American,医院和卫生设施的领导运营商)的母公司)的董事会成员。他是 Pinnacle Financial Partners的前董事和亚特兰大联邦储备银行(the Federal Reserve Bank of Atlanta)纳什维尔分行委员会前董事。他获得耶鲁大学(Yale University )的学士学位、杜兰大学(Tulane University)公共卫生与热带医学学院的健康系统管理硕士学位、莱斯大学(Rice University)琼斯管理研究生院(Jones Graduate School of Management)的工商管理硕士学位以及其豪斯医学院(the Morehouse School of Medicine)的硕士学位。
Wayne J. Riley,has served as president of SUNY Downstate Health Sciences University since April 2017, where he is also a tenured professor of internal medicine and health policy and management. From 2013 to 2017, he was Adjunct Professor of Healthcare Management, Owen Graduate School of Management, Vanderbilt University and Clinical Professor of Medicine, Vanderbilt University School of Medicine. From 2007 to 2013, he served as President and CEO of Meharry Medical College. From 2003 through 2006, Dr. Riley served as Vice-President and Vice Dean for Health Affairs and Governmental Relations, Baylor College of Medicine. Dr. Riley has also served as a director of Compass Pathways, plc since 2021 and HeartFlow, Inc. since 2021. Dr. Riley served as a director of Vertex Pharmaceuticals Incorporated from 2010 to 2015, Pinnacle Financial Partners, Inc. from 2007 to 2013 and the Federal Reserve Board of Atlanta, Nashville Branch from January 2013 to June 2013. He is President Emeritus of the American College of Physicians and an elected member of the National Academy of Medicine. Dr. Riley is also a Commissioner of the Medicare Payment Advisory Commission (MedPAC) and Chair of the Board of Trustees of The New York Academy of Medicine.
Robert J. Dennis

Robert J. Dennis,2013年2月被任命为董事,现为本公司薪酬委员会成员。他是Genesco的董事长、总裁、首席执行官,这是经营鞋帽、运动服装及配件的多元化零售公司,他自2004年起担任经理人员。他在零售业有着27年的丰富经验,曾在Hat World Corporation 和 Asbury Automotive担任过高级职务;也曾是国际咨询公司麦肯锡北美零售业务的合伙人、负责人。他以优异成绩获得了哈佛商学院消费者营销方向的工商管理硕士学位、Rensselaer Polytechnic Institute的学士和硕士学位。截止2014年2月,他是HCA Holdings的董事,这是著名的在美国和英国伦敦经营医院和手术中心的医疗健康服务公司。之前,他曾是Teavana Holdings的董事,该公司经营高品质的茶和茶制品,直到2012年12月它被星巴克收购。目前,他任职于the United Way of Metropolitan Nashville、纳什维尔交响乐队的董事会,以及Vanderbilt University's Owen School of Management的监事会。


Robert J. Dennis,served as Executive Chairman of Genesco Inc., a specialty retailer, from February 2020 until June 2020. Previously, he served as Genesco's President and Chief Executive Officer from 2008 to February 2020 and as Chairman from April 2010 to February 2020. Mr. Dennis served as Genesco's President and Chief Operating Officer from 2006 until 2008, Executive Vice President and Chief Operating Officer from 2005 until 2006 and Senior Vice President from 2004 until 2005. He previously served as Chief Executive Officer of Hat World Corporation from 2001 to 2004. Mr. Dennis has also served as a director of CoreCivic, Inc. since February 2013 and as a director of Teavana Holdings, Inc. from 2011 to 2012.
Robert J. Dennis,2013年2月被任命为董事,现为本公司薪酬委员会成员。他是Genesco的董事长、总裁、首席执行官,这是经营鞋帽、运动服装及配件的多元化零售公司,他自2004年起担任经理人员。他在零售业有着27年的丰富经验,曾在Hat World Corporation 和 Asbury Automotive担任过高级职务;也曾是国际咨询公司麦肯锡北美零售业务的合伙人、负责人。他以优异成绩获得了哈佛商学院消费者营销方向的工商管理硕士学位、Rensselaer Polytechnic Institute的学士和硕士学位。截止2014年2月,他是HCA Holdings的董事,这是著名的在美国和英国伦敦经营医院和手术中心的医疗健康服务公司。之前,他曾是Teavana Holdings的董事,该公司经营高品质的茶和茶制品,直到2012年12月它被星巴克收购。目前,他任职于the United Way of Metropolitan Nashville、纳什维尔交响乐队的董事会,以及Vanderbilt University's Owen School of Management的监事会。
Robert J. Dennis,served as Executive Chairman of Genesco Inc., a specialty retailer, from February 2020 until June 2020. Previously, he served as Genesco's President and Chief Executive Officer from 2008 to February 2020 and as Chairman from April 2010 to February 2020. Mr. Dennis served as Genesco's President and Chief Operating Officer from 2006 until 2008, Executive Vice President and Chief Operating Officer from 2005 until 2006 and Senior Vice President from 2004 until 2005. He previously served as Chief Executive Officer of Hat World Corporation from 2001 to 2004. Mr. Dennis has also served as a director of CoreCivic, Inc. since February 2013 and as a director of Teavana Holdings, Inc. from 2011 to 2012.
Hugh F. Johnston

Hugh F. Johnston,他于1987年加入百事公司,并担任各种职务,包括百事公司全球运营执行副总裁;百事可乐北美区总裁;百事公司转型高级副总裁;百事饮料和食品公司高级副总裁兼首席财务官;百事公司负责并购的高级副总裁。1999年至2002年,他曾担任Merck & Co.的零售副总裁。Johnston于2010年被任命为百事公司的首席财务官,负责为百事公司提供战略财务领导,包括确保公司的战略为股东创造价值,向投资者传达公司的战略和业绩,实施资本结构,财务流程和控制,以支持公司的增长和投资回报目标。Johnston目前担任Microsoft Corp.的董事会成员和审计委员会主席,以及HCA Healthcare的董事会成员和审计委员会主席。他还是全球领先的经济智库彼得森国际经济研究所(Peterson Institute for International Economics)的主任。他持有Syracuse University的理学学士学位和University of Chicago的工商管理硕士学位。


Hugh F. Johnston,joined PepsiCo in 1987, and has held a variety of roles, including Executive Vice President, Global Operations, PepsiCo; President, Pepsi-Cola North America; Senior Vice President, Transformation, PepsiCo; Senior Vice President and Chief Financial Officer, PepsiCo Beverages and Foods; and Senior Vice President, Mergers and Acquisitions, PepsiCo. Johnston also served as Vice President, Retail at Merck & Co. from 1999 until 2002, when he rejoined PepsiCo. Johnston was named CFO of PepsiCo in 2010 and has been responsible for providing strategic financial leadership for PepsiCo, including ensuring the company's strategy creates shareholder value, communicating the company's strategies and performance to investors, and implementing a capital structure, financial processes and controls to support the company's growth and return on investment goals. Johnston currently serves as a member of the board and chair of the audit committee of Microsoft Corp., and as a member of the board and chair of the audit committee of HCA Healthcare. He is also a director for the Peterson Institute for International Economics, a leading global economic think tank. Johnston holds a Bachelor of Science degree from Syracuse University and an M.B.A. from the University of Chicago.
Hugh F. Johnston,他于1987年加入百事公司,并担任各种职务,包括百事公司全球运营执行副总裁;百事可乐北美区总裁;百事公司转型高级副总裁;百事饮料和食品公司高级副总裁兼首席财务官;百事公司负责并购的高级副总裁。1999年至2002年,他曾担任Merck & Co.的零售副总裁。Johnston于2010年被任命为百事公司的首席财务官,负责为百事公司提供战略财务领导,包括确保公司的战略为股东创造价值,向投资者传达公司的战略和业绩,实施资本结构,财务流程和控制,以支持公司的增长和投资回报目标。Johnston目前担任Microsoft Corp.的董事会成员和审计委员会主席,以及HCA Healthcare的董事会成员和审计委员会主席。他还是全球领先的经济智库彼得森国际经济研究所(Peterson Institute for International Economics)的主任。他持有Syracuse University的理学学士学位和University of Chicago的工商管理硕士学位。
Hugh F. Johnston,joined PepsiCo in 1987, and has held a variety of roles, including Executive Vice President, Global Operations, PepsiCo; President, Pepsi-Cola North America; Senior Vice President, Transformation, PepsiCo; Senior Vice President and Chief Financial Officer, PepsiCo Beverages and Foods; and Senior Vice President, Mergers and Acquisitions, PepsiCo. Johnston also served as Vice President, Retail at Merck & Co. from 1999 until 2002, when he rejoined PepsiCo. Johnston was named CFO of PepsiCo in 2010 and has been responsible for providing strategic financial leadership for PepsiCo, including ensuring the company's strategy creates shareholder value, communicating the company's strategies and performance to investors, and implementing a capital structure, financial processes and controls to support the company's growth and return on investment goals. Johnston currently serves as a member of the board and chair of the audit committee of Microsoft Corp., and as a member of the board and chair of the audit committee of HCA Healthcare. He is also a director for the Peterson Institute for International Economics, a leading global economic think tank. Johnston holds a Bachelor of Science degree from Syracuse University and an M.B.A. from the University of Chicago.
William R. Frist

William R. Frist是Frist Capital LLC(Frist先生和某些相关人员的私人投资工具)的负责人,自2003年以来担任该职位。他也是Frisco Partners(另一个Frist家庭投资工具)的普通合伙人。他是Thomas F. Frist III(也是公司的董事)的兄弟。


William R. Frist,is a principal of Frist Capital, LLC, a Nashville-based investment firm, and has held this position since 2003. Mr. Frist currently serves as Chairman of The Frist Foundation and Chair and President of the Board of Trustees of the Frist Art Museum. Mr. Frist is the brother of Thomas F. Frist III, who also serves as a director of the Company.
William R. Frist是Frist Capital LLC(Frist先生和某些相关人员的私人投资工具)的负责人,自2003年以来担任该职位。他也是Frisco Partners(另一个Frist家庭投资工具)的普通合伙人。他是Thomas F. Frist III(也是公司的董事)的兄弟。
William R. Frist,is a principal of Frist Capital, LLC, a Nashville-based investment firm, and has held this position since 2003. Mr. Frist currently serves as Chairman of The Frist Foundation and Chair and President of the Board of Trustees of the Frist Art Museum. Mr. Frist is the brother of Thomas F. Frist III, who also serves as a director of the Company.
Nancy Ann M. DeParle

Nancy Ann M. DeParle她自2013年8月起出任私人股权投资公司调和Capital Partners LLC联合创始人合伙人。她自2013年8月起出任私人股权投资公司Consonance Capital Partners, LLC联合创始人合伙人。该公司为一家专注于投资小型和中等规模的医疗保健公司。2009年3月至2013年1月,她供职于白宫,首先作为总统顾问,后来任白宫健康改革办公室主任,离职前任总统及副参谋长政策助理。此外, 1993至2000年,她曾经担任白宫办公室管理和预算办公室健康和人员副主任,后来作为医疗保险中心和医疗补助服务处管理员。2001年到2009年3月,她曾任摩根大通 高级顾问和CCMP Capital, L.L.C的常务董事。CCMP Capital, L.L.C专于面向医疗保健公司私募股权投资。 她现任医疗保健服务公司HCA控股公司董事,该公司拥有,管理或经营医院与其他医疗机构。


Nancy Ann M. DeParle,is a co-founder of Consonance Capital Partners, a private equity firm, and has also served as a managing partner of the firm since January 2020. She previously served as a partner of the firm from 2013 to 2019. From March 2009 to January 2013, Ms. DeParle served in the White House, first as Counselor to the President and Director of the White House Office of Health Reform, and later as Assistant to the President and Deputy Chief of Staff for Policy. From 2001 to 2009, Ms. DeParle was a senior advisor and managing director of JPMorgan Partners and its successor, CCMP Capital. From 1993 to 2000, Ms. DeParle served as the Associate Director for Health and Personnel for the White House Office of Management and Budget, and later as the Administrator of the Centers for Medicare and Medicaid Services (then known as the Health Care Financing Administration). Ms. DeParle has also served as a director of CVS Health Corporation since September 2013.
Nancy Ann M. DeParle她自2013年8月起出任私人股权投资公司调和Capital Partners LLC联合创始人合伙人。她自2013年8月起出任私人股权投资公司Consonance Capital Partners, LLC联合创始人合伙人。该公司为一家专注于投资小型和中等规模的医疗保健公司。2009年3月至2013年1月,她供职于白宫,首先作为总统顾问,后来任白宫健康改革办公室主任,离职前任总统及副参谋长政策助理。此外, 1993至2000年,她曾经担任白宫办公室管理和预算办公室健康和人员副主任,后来作为医疗保险中心和医疗补助服务处管理员。2001年到2009年3月,她曾任摩根大通 高级顾问和CCMP Capital, L.L.C的常务董事。CCMP Capital, L.L.C专于面向医疗保健公司私募股权投资。 她现任医疗保健服务公司HCA控股公司董事,该公司拥有,管理或经营医院与其他医疗机构。
Nancy Ann M. DeParle,is a co-founder of Consonance Capital Partners, a private equity firm, and has also served as a managing partner of the firm since January 2020. She previously served as a partner of the firm from 2013 to 2019. From March 2009 to January 2013, Ms. DeParle served in the White House, first as Counselor to the President and Director of the White House Office of Health Reform, and later as Assistant to the President and Deputy Chief of Staff for Policy. From 2001 to 2009, Ms. DeParle was a senior advisor and managing director of JPMorgan Partners and its successor, CCMP Capital. From 1993 to 2000, Ms. DeParle served as the Associate Director for Health and Personnel for the White House Office of Management and Budget, and later as the Administrator of the Centers for Medicare and Medicaid Services (then known as the Health Care Financing Administration). Ms. DeParle has also served as a director of CVS Health Corporation since September 2013.

高管简历

中英对照 |  中文 |  英文
Samuel N. Hazen

Samuel N. Hazen在2011年2月被任命为公司运营的总裁。他从2001年7月到2011年2月担任西方集团的总裁,从1995年8月到2001年7月担任公司西方集团的首席财务官。他从1994年2月到1995年7月担任公司北德克萨斯的首席财务官。在此之前,他在不同医院工作,在Humana Inc.和Galen Health Care, Inc.担任区域财务总监职位。


Samuel N. Hazen,has served as Chief Executive Officer since January 2019. From November 2016 through December 2018, Mr. Hazen served as the Company's President and Chief Operating Officer. Prior to that, he served as Chief Operating Officer of the Company from January 2015 to November 2016 and as President — Operations of the Company from 2011 to 2015. He also served as President — Western Group from 2001 to 2011 and as Chief Financial Officer — Western Group of the Company from 1995 to 2001. Prior to that time, Mr. Hazen served in various hospital, regional and division Chief Financial Officer positions with the Company, Humana Inc. and Galen Health Care, Inc.
Samuel N. Hazen在2011年2月被任命为公司运营的总裁。他从2001年7月到2011年2月担任西方集团的总裁,从1995年8月到2001年7月担任公司西方集团的首席财务官。他从1994年2月到1995年7月担任公司北德克萨斯的首席财务官。在此之前,他在不同医院工作,在Humana Inc.和Galen Health Care, Inc.担任区域财务总监职位。
Samuel N. Hazen,has served as Chief Executive Officer since January 2019. From November 2016 through December 2018, Mr. Hazen served as the Company's President and Chief Operating Officer. Prior to that, he served as Chief Operating Officer of the Company from January 2015 to November 2016 and as President — Operations of the Company from 2011 to 2015. He also served as President — Western Group from 2001 to 2011 and as Chief Financial Officer — Western Group of the Company from 1995 to 2001. Prior to that time, Mr. Hazen served in various hospital, regional and division Chief Financial Officer positions with the Company, Humana Inc. and Galen Health Care, Inc.
Michael S. Cuffe

Michael S. Cuffe,他曾一直担任Physician Services Group的总裁(2011年10月以来)。从2011年10月到2011年1月,他担任公司的副总裁。此前,他曾担任Duke University Health System的门诊服务副总裁兼首席医疗官(从2011年3月到2011年10月)、医学事务副总裁(从2005年6月到2011年3月)。他也曾担任Duke University School of Medicine的医学事务副院长(从2008年6月到2011年3月)、医学系副主任(从2009年8月到2010年8月)、医学副教授(从2005年3月到2011年10月)。此前,他曾担任the Duke Clinical Research Institute、Duke University Medical Center、Duke University School of Medicine的多种领导职务。


Michael S. Cuffe,M.D. was appointed Executive Vice President and Chief Clinical Officer effective January 1, 2022. He previously served as President — Physician Services Group from October 2011 through December 2021. From October 2011 to January 2015, Dr. Cuffe also served as a Vice President of the Company. Prior to that time, Dr. Cuffe served Duke University Health System as Vice President for Ambulatory Services and Chief Medical Officer from March 2011 to October 2011 and Vice President Medical Affairs from June 2005 to March 2011. He also served Duke University School of Medicine as Vice Dean for Medical Affairs from June 2008 to March 2011, Deputy Chair of the Department of Medicine from August 2009 to August 2010 and Associate Professor of Medicine from March 2005 to October 2011. Prior that time, Dr. Cuffe served in various leadership roles with the Duke Clinical Research Institute, Duke University Medical Center and Duke University School of Medicine.
Michael S. Cuffe,他曾一直担任Physician Services Group的总裁(2011年10月以来)。从2011年10月到2011年1月,他担任公司的副总裁。此前,他曾担任Duke University Health System的门诊服务副总裁兼首席医疗官(从2011年3月到2011年10月)、医学事务副总裁(从2005年6月到2011年3月)。他也曾担任Duke University School of Medicine的医学事务副院长(从2008年6月到2011年3月)、医学系副主任(从2009年8月到2010年8月)、医学副教授(从2005年3月到2011年10月)。此前,他曾担任the Duke Clinical Research Institute、Duke University Medical Center、Duke University School of Medicine的多种领导职务。
Michael S. Cuffe,M.D. was appointed Executive Vice President and Chief Clinical Officer effective January 1, 2022. He previously served as President — Physician Services Group from October 2011 through December 2021. From October 2011 to January 2015, Dr. Cuffe also served as a Vice President of the Company. Prior to that time, Dr. Cuffe served Duke University Health System as Vice President for Ambulatory Services and Chief Medical Officer from March 2011 to October 2011 and Vice President Medical Affairs from June 2005 to March 2011. He also served Duke University School of Medicine as Vice Dean for Medical Affairs from June 2008 to March 2011, Deputy Chair of the Department of Medicine from August 2009 to August 2010 and Associate Professor of Medicine from March 2005 to October 2011. Prior that time, Dr. Cuffe served in various leadership roles with the Duke Clinical Research Institute, Duke University Medical Center and Duke University School of Medicine.
Kathryn A. Torres

Kathryn A. Torres,于2016年7月被任命为高级副总裁,负责雇主和付款人业务。她于1993年加入HCA,也曾担任多种职务,包括雇主和付款人业务副总裁,以及战略副总裁。


Kathryn A. Torres,was appointed Senior Vice President — Payer Contracting and Alignment (formerly Senior Vice President — Employer and Payer Engagement) in July 2016. Ms. Torres joined HCA in 1993 and served in various capacities, including as Vice President of Employer and Payer Engagement and Vice President — Strategy.
Kathryn A. Torres,于2016年7月被任命为高级副总裁,负责雇主和付款人业务。她于1993年加入HCA,也曾担任多种职务,包括雇主和付款人业务副总裁,以及战略副总裁。
Kathryn A. Torres,was appointed Senior Vice President — Payer Contracting and Alignment (formerly Senior Vice President — Employer and Payer Engagement) in July 2016. Ms. Torres joined HCA in 1993 and served in various capacities, including as Vice President of Employer and Payer Engagement and Vice President — Strategy.
Christopher F. Wyatt

Christopher F. Wyatt,他于2016年4月被任命为高级副总裁兼总会计师。此前,他曾担任公司的副总裁兼首席财务官,负责信息技术(从2013年1月到2016年4月),以及临床服务集团的首席财务官(从2010年10月到2013年1月)。从2000年到2010年,他曾担任安永会计师事务所(Ernst & Young)的多种职务。


Christopher F. Wyatt,was appointed Senior Vice President and Controller in April 2016. Prior to that time, Mr. Wyatt served the Company as Vice President and Chief Financial Officer — IT&S from January 2013 to April 2016 and Chief Financial Officer — Clinical Services Group from October 2010 until January 2013. From 2000 to 2010, Mr. Wyatt served in various capacities with Ernst & Young LLP.
Christopher F. Wyatt,他于2016年4月被任命为高级副总裁兼总会计师。此前,他曾担任公司的副总裁兼首席财务官,负责信息技术(从2013年1月到2016年4月),以及临床服务集团的首席财务官(从2010年10月到2013年1月)。从2000年到2010年,他曾担任安永会计师事务所(Ernst & Young)的多种职务。
Christopher F. Wyatt,was appointed Senior Vice President and Controller in April 2016. Prior to that time, Mr. Wyatt served the Company as Vice President and Chief Financial Officer — IT&S from January 2013 to April 2016 and Chief Financial Officer — Clinical Services Group from October 2010 until January 2013. From 2000 to 2010, Mr. Wyatt served in various capacities with Ernst & Young LLP.
Phillip G. Billington

Phillip G. Billington于2019年1月1日被任命为内部审计服务高级副总裁。Billington先生于2005年6月至2018年12月担任公司内部审计副总裁。在加入HCA之前,Billington先生担任董事总经理 FTI Consulting,Inc.,KPMG LLP董事,Arthur Andersen LLP高级经理。


Phillip G. Billington,was appointed Senior Vice President — Internal Audit Services effective January 1, 2019. Mr. Billington previously served as Vice President — Corporate Internal Audit from June 2005 to December 2018. Prior to joining HCA, Mr. Billington worked as a managing director for FTI Consulting, Inc., a director for KPMG LLP and was a senior manager at Arthur Andersen LLP.
Phillip G. Billington于2019年1月1日被任命为内部审计服务高级副总裁。Billington先生于2005年6月至2018年12月担任公司内部审计副总裁。在加入HCA之前,Billington先生担任董事总经理 FTI Consulting,Inc.,KPMG LLP董事,Arthur Andersen LLP高级经理。
Phillip G. Billington,was appointed Senior Vice President — Internal Audit Services effective January 1, 2019. Mr. Billington previously served as Vice President — Corporate Internal Audit from June 2005 to December 2018. Prior to joining HCA, Mr. Billington worked as a managing director for FTI Consulting, Inc., a director for KPMG LLP and was a senior manager at Arthur Andersen LLP.
Deborah M. Reiner

Deborah M. Reiner于2017年10月被任命为市场营销和传播高级副总裁。在此之前,她于2017年8月至2017年10月担任营销和客户关系管理副总裁,并于2012年1月起担任客户关系管理副总裁。 2017年8月。Reiner女士于2000年加入公司,并于2000年至2012年担任公司山地部门的多个职位。


Deborah M. Reiner,was appointed Senior Vice President — Marketing and Communications in October 2017. Prior to that time, she served as Vice President of Marketing and Customer Relationship Management from August 2017 to October 2017 and Vice President of Customer Relationship Management from January 2012 to August 2017. Ms. Reiner joined the Company in 2000 and served in various roles with the Company's Mountain Division from 2000 to 2012.
Deborah M. Reiner于2017年10月被任命为市场营销和传播高级副总裁。在此之前,她于2017年8月至2017年10月担任营销和客户关系管理副总裁,并于2012年1月起担任客户关系管理副总裁。 2017年8月。Reiner女士于2000年加入公司,并于2000年至2012年担任公司山地部门的多个职位。
Deborah M. Reiner,was appointed Senior Vice President — Marketing and Communications in October 2017. Prior to that time, she served as Vice President of Marketing and Customer Relationship Management from August 2017 to October 2017 and Vice President of Customer Relationship Management from January 2012 to August 2017. Ms. Reiner joined the Company in 2000 and served in various roles with the Company's Mountain Division from 2000 to 2012.
Kathleen M. Whalen

Kathleen M. Whalen自2019年1月1日起被任命为高级副总裁兼首席道德与合规官。在此之前,Whalen女士于2013年8月至2018年12月担任道德与合规副总裁兼道德与合规助理副总裁 计划开发于2000年3月至2013年7月。在1998年1月加入HCA之前,Whalen女士曾担任克林顿总统的副法律顾问,负责白宫的道德计划。 她在美国商务部总法律顾问办公室的道德部门开始接受政府服务。 在此之前,她在俄亥俄州代顿市从事劳动和就业法律。


Kathleen M. Whalen,was appointed Senior Vice President and Chief Ethics and Compliance Officer effective January 1, 2019. Prior to that time, Ms. Whalen served as Vice President — Ethics and Compliance from August 2013 through December 2018 and Assistant Vice President — Ethics and Compliance Program Development from March 2000 through July 2013. Prior to joining HCA in January 1998, Ms. Whalen served as Associate Counsel to President Clinton with responsibility for the White House's ethics program. She began her government service in the ethics division of the General Counsel's Office at the U.S. Commerce Department. Prior to that, she practiced labor and employment law in Dayton, Ohio.
Kathleen M. Whalen自2019年1月1日起被任命为高级副总裁兼首席道德与合规官。在此之前,Whalen女士于2013年8月至2018年12月担任道德与合规副总裁兼道德与合规助理副总裁 计划开发于2000年3月至2013年7月。在1998年1月加入HCA之前,Whalen女士曾担任克林顿总统的副法律顾问,负责白宫的道德计划。 她在美国商务部总法律顾问办公室的道德部门开始接受政府服务。 在此之前,她在俄亥俄州代顿市从事劳动和就业法律。
Kathleen M. Whalen,was appointed Senior Vice President and Chief Ethics and Compliance Officer effective January 1, 2019. Prior to that time, Ms. Whalen served as Vice President — Ethics and Compliance from August 2013 through December 2018 and Assistant Vice President — Ethics and Compliance Program Development from March 2000 through July 2013. Prior to joining HCA in January 1998, Ms. Whalen served as Associate Counsel to President Clinton with responsibility for the White House's ethics program. She began her government service in the ethics division of the General Counsel's Office at the U.S. Commerce Department. Prior to that, she practiced labor and employment law in Dayton, Ohio.
Jennifer L. Berres

Jennifer L. Berres被任命为高级副总裁兼首席人力资源官,于2019年11月1日生效。贝瑞斯女士于1993年加入HCA,并担任过各种职务,包括从2013年4月至2019年10月担任人力资源副总裁。


Jennifer L. Berres,was appointed Senior Vice President and Chief Human Resources Officer effective November 1, 2019. Ms. Berres joined HCA in 1993 and served in various capacities, including as Vice President — Human Resources from April 2013 through October 2019.
Jennifer L. Berres被任命为高级副总裁兼首席人力资源官,于2019年11月1日生效。贝瑞斯女士于1993年加入HCA,并担任过各种职务,包括从2013年4月至2019年10月担任人力资源副总裁。
Jennifer L. Berres,was appointed Senior Vice President and Chief Human Resources Officer effective November 1, 2019. Ms. Berres joined HCA in 1993 and served in various capacities, including as Vice President — Human Resources from April 2013 through October 2019.
Jeff E. Cohen

Jeff E. Cohen被任命为政府关系高级副总裁,于2019年10月1日生效。在加入HCA之前,科恩先生在美国医院联合会工作了20年,最近担任公共事务执行副总裁,负责所有宣传工作。 公共事务和传播协会。


Jeff E. Cohen,was appointed Senior Vice President — Government Relations effective October 1, 2019. Prior to joining HCA, Mr. Cohen spent 20 years with the Federation of American Hospitals, most recently as Executive Vice President of Public Affairs, where he managed all advocacy, public affairs and communications for the association.
Jeff E. Cohen被任命为政府关系高级副总裁,于2019年10月1日生效。在加入HCA之前,科恩先生在美国医院联合会工作了20年,最近担任公共事务执行副总裁,负责所有宣传工作。 公共事务和传播协会。
Jeff E. Cohen,was appointed Senior Vice President — Government Relations effective October 1, 2019. Prior to joining HCA, Mr. Cohen spent 20 years with the Federation of American Hospitals, most recently as Executive Vice President of Public Affairs, where he managed all advocacy, public affairs and communications for the association.
Michael R. McAlevey

Michael R. McAlevey ,于2022年1月被任命为高级副总裁兼首席法律官。在加入HCA之前,McAlevey 曾在通用电气担任高级法律和行政职务,最近一次是从2018年起担任GE Healthcare的副总裁、总法律顾问和业务发展负责人。在此之前,他曾于2011年至2018年担任通用电气航空的总法律顾问和业务发展负责人,并于2003年至2011年担任通用电气的首席企业、证券和财务顾问。在加入通用电气之前,McAlevey 曾于1998年至2002年担任美国证券交易委员会公司财务部副主任。


Michael R. McAlevey,was appointed Senior Vice President and Chief Legal Officer in January 2022. Prior to joining HCA, Mr. McAlevey served in senior legal and executive roles at General Electric, most recently as Vice President, General Counsel and Business Development Leader for GE Healthcare since 2018. Prior to that, he served as General Counsel and Business Development Leader for GE Aviation from 2011 to 2018 and Chief Corporate, Securities and Finance Counsel for GE from 2003 to 2011. Before joining GE, Mr. McAlevey served as Deputy Director of the United States Securities and Exchange Commission's Division of Corporation Finance from 1998 to 2002.
Michael R. McAlevey ,于2022年1月被任命为高级副总裁兼首席法律官。在加入HCA之前,McAlevey 曾在通用电气担任高级法律和行政职务,最近一次是从2018年起担任GE Healthcare的副总裁、总法律顾问和业务发展负责人。在此之前,他曾于2011年至2018年担任通用电气航空的总法律顾问和业务发展负责人,并于2003年至2011年担任通用电气的首席企业、证券和财务顾问。在加入通用电气之前,McAlevey 曾于1998年至2002年担任美国证券交易委员会公司财务部副主任。
Michael R. McAlevey,was appointed Senior Vice President and Chief Legal Officer in January 2022. Prior to joining HCA, Mr. McAlevey served in senior legal and executive roles at General Electric, most recently as Vice President, General Counsel and Business Development Leader for GE Healthcare since 2018. Prior to that, he served as General Counsel and Business Development Leader for GE Aviation from 2011 to 2018 and Chief Corporate, Securities and Finance Counsel for GE from 2003 to 2011. Before joining GE, Mr. McAlevey served as Deputy Director of the United States Securities and Exchange Commission's Division of Corporation Finance from 1998 to 2002.
Sammie S. Mosier

Sammie S. Mosier被任命为高级副总裁和首席执行官执行2021年12月1日生效。Mosier博士于1992加入HCA,作为法兰克福地区医疗中心的内科外科床边护士,并在2019至2021年间担任过副总裁和助理首席护理执行-临床服务小组。


Sammie S. Mosier,was appointed Senior Vice President and Chief Nurse Executive effective December 1, 2021. Dr. Mosier joined HCA in 1992 as a medical-surgical bedside nurse at Frankfort Regional Medical Center and has held progressive leadership roles, including as Vice President and Assistant Chief Nursing Executive — Clinical Services Group from 2019 to 2021.
Sammie S. Mosier被任命为高级副总裁和首席执行官执行2021年12月1日生效。Mosier博士于1992加入HCA,作为法兰克福地区医疗中心的内科外科床边护士,并在2019至2021年间担任过副总裁和助理首席护理执行-临床服务小组。
Sammie S. Mosier,was appointed Senior Vice President and Chief Nurse Executive effective December 1, 2021. Dr. Mosier joined HCA in 1992 as a medical-surgical bedside nurse at Frankfort Regional Medical Center and has held progressive leadership roles, including as Vice President and Assistant Chief Nursing Executive — Clinical Services Group from 2019 to 2021.
Erol R. Akdamar

Erol R. Akdamar于2023年1月1日被任命为American Group总裁。Akdamar先生曾于2013年10月至2022年12月担任North Texas Division总裁。在此之前,他于2010年至2013年担任德克萨斯州达拉斯医疗城达拉斯医院的首席执行官,并于2004年至2010年担任德克萨斯奥斯汀圣大卫南奥斯汀医疗中心的首席执行长。Akdamar先生于1993年在Rapides地区医疗中心开始了他的HCA职业生涯。


Erol R. Akdamar,was appointed President – American Group effective January 1, 2023. Mr. Akdamar previously served as President of the North Texas Division from October 2013 to December 2022. Prior to that, he served as CEO of Medical City Dallas Hospital in Dallas, Texas from 2010 to 2013 and CEO of St. David's South Austin Medical Center in Austin, Texas from 2004 to 2010. Mr. Akdamar began his career with HCA in 1993 with Rapides Regional Medical Center.
Erol R. Akdamar于2023年1月1日被任命为American Group总裁。Akdamar先生曾于2013年10月至2022年12月担任North Texas Division总裁。在此之前,他于2010年至2013年担任德克萨斯州达拉斯医疗城达拉斯医院的首席执行官,并于2004年至2010年担任德克萨斯奥斯汀圣大卫南奥斯汀医疗中心的首席执行长。Akdamar先生于1993年在Rapides地区医疗中心开始了他的HCA职业生涯。
Erol R. Akdamar,was appointed President – American Group effective January 1, 2023. Mr. Akdamar previously served as President of the North Texas Division from October 2013 to December 2022. Prior to that, he served as CEO of Medical City Dallas Hospital in Dallas, Texas from 2010 to 2013 and CEO of St. David's South Austin Medical Center in Austin, Texas from 2004 to 2010. Mr. Akdamar began his career with HCA in 1993 with Rapides Regional Medical Center.
Michael A. Marks

Michael A. Marks被任命为高级副总裁——财务,自2023年1月1日起生效。Marks先生曾于2021年3月至2022年12月担任副总裁——财务运营支持。在此之前,他于2008年12月至2021年2月担任National GroupCFO,于2006年1月至2008年11月担任西佛罗里达分部CFO。Marks先生于1996年加入HCA医疗保健公司。


Michael A. Marks,was appointed Senior Vice President — Finance effective January 1, 2023. Mr. Marks previously served as Vice President — Financial Operations Support from March 2021 to December 2022. Prior to that time, he served as CFO of the National Group from December 2008 to February 2021 and CFO of the West Florida Division from January 2006 to November 2008. Mr. Marks joined HCA Healthcare in 1996.
Michael A. Marks被任命为高级副总裁——财务,自2023年1月1日起生效。Marks先生曾于2021年3月至2022年12月担任副总裁——财务运营支持。在此之前,他于2008年12月至2021年2月担任National GroupCFO,于2006年1月至2008年11月担任西佛罗里达分部CFO。Marks先生于1996年加入HCA医疗保健公司。
Michael A. Marks,was appointed Senior Vice President — Finance effective January 1, 2023. Mr. Marks previously served as Vice President — Financial Operations Support from March 2021 to December 2022. Prior to that time, he served as CFO of the National Group from December 2008 to February 2021 and CFO of the West Florida Division from January 2006 to November 2008. Mr. Marks joined HCA Healthcare in 1996.
Richard A. Hammett

Richard A. Hammett被任命为总裁——Atlantic Group总裁,自2023年1月1日起生效。Hammett先生曾于2020年6月至2022年12月担任North Florida Division总裁。在此之前,他曾于2015年至2020年担任Swedish Medical Center in Englewood, Colorado的总裁兼首席执行官。在此之前,Hammett曾在HCA医疗保健公司担任多个领导职务,包括担任The Medical Center of Aurora in Aurora, Colorado的总裁兼首席执行官,以及St. David's Medical Center in Austin, Texas的首席运营官兼临时首席执行官。


Richard A. Hammett,was appointed President — Atlantic Group effective January 1, 2023. Mr. Hammett previously served as President of the North Florida Division from June 2020 to December 2022. Prior to that, he served as President and CEO of Swedish Medical Center in Englewood, Colorado from 2015 to 2020. Prior to that time, Mr. Hammett held numerous leadership positions within HCA Healthcare, including serving as president and chief executive officer of The Medical Center of Aurora in Aurora, Colorado and chief operating officer and interim CEO of St. David's Medical Center in Austin, Texas.
Richard A. Hammett被任命为总裁——Atlantic Group总裁,自2023年1月1日起生效。Hammett先生曾于2020年6月至2022年12月担任North Florida Division总裁。在此之前,他曾于2015年至2020年担任Swedish Medical Center in Englewood, Colorado的总裁兼首席执行官。在此之前,Hammett曾在HCA医疗保健公司担任多个领导职务,包括担任The Medical Center of Aurora in Aurora, Colorado的总裁兼首席执行官,以及St. David's Medical Center in Austin, Texas的首席运营官兼临时首席执行官。
Richard A. Hammett,was appointed President — Atlantic Group effective January 1, 2023. Mr. Hammett previously served as President of the North Florida Division from June 2020 to December 2022. Prior to that, he served as President and CEO of Swedish Medical Center in Englewood, Colorado from 2015 to 2020. Prior to that time, Mr. Hammett held numerous leadership positions within HCA Healthcare, including serving as president and chief executive officer of The Medical Center of Aurora in Aurora, Colorado and chief operating officer and interim CEO of St. David's Medical Center in Austin, Texas.
Timothy M. McManus

Timothy M. McManus被任命为National Group总裁,自2023年1月1日起生效。McManus先生曾于2016年8月至2022年12月担任资Timothy M. McManus总裁。McManus先生于2007年加入HCA医疗保健公司,2012年6月至2016年7月担任弗吉尼亚州里士满Chippenham和Johnston-Willis医疗中心首席执行官,2010年6月至2012年6月担任弗吉尼亚州雷斯顿Reston医疗中心首席执行官,2007年9月至2010年5月担任密西西比州格尔夫波特Garden Park医疗中心首席执行官。


Timothy M. McManus,was appointed President — National Group effective January 1, 2023. Mr. McManus previously served as President of the Capital Division from August 2016 to December 2022. Mr. McManus joined HCA Healthcare in 2007 and served as CEO of Chippenham and Johnston-Willis Medical Center in Richmond, Virginia from June 2012 to July 2016, CEO of Reston Medical Center in Reston, Virginia from June 2010 to June 2012 and CEO of Garden Park Medical Center in Gulfport, Mississippi from September 2007 to May 2010.
Timothy M. McManus被任命为National Group总裁,自2023年1月1日起生效。McManus先生曾于2016年8月至2022年12月担任资Timothy M. McManus总裁。McManus先生于2007年加入HCA医疗保健公司,2012年6月至2016年7月担任弗吉尼亚州里士满Chippenham和Johnston-Willis医疗中心首席执行官,2010年6月至2012年6月担任弗吉尼亚州雷斯顿Reston医疗中心首席执行官,2007年9月至2010年5月担任密西西比州格尔夫波特Garden Park医疗中心首席执行官。
Timothy M. McManus,was appointed President — National Group effective January 1, 2023. Mr. McManus previously served as President of the Capital Division from August 2016 to December 2022. Mr. McManus joined HCA Healthcare in 2007 and served as CEO of Chippenham and Johnston-Willis Medical Center in Richmond, Virginia from June 2012 to July 2016, CEO of Reston Medical Center in Reston, Virginia from June 2010 to June 2012 and CEO of Garden Park Medical Center in Gulfport, Mississippi from September 2007 to May 2010.
Charles J. Hall

Charles J. Hall于2011年2月被任命为国家集团的总裁。在此之前,他从2006年10月到2011年2月担任东方集团的总裁。他之前从2003年4月到2006年10月担任公司北佛罗里达部门的总裁,从1999年1月到2003年4月担任东佛罗里达部门的总裁,从1998年1月到1998年12月担任东佛罗里达部门的市场总裁,从1996年2月到1997年12月担任南佛罗里达部门的总裁,从1994年10月到1996年2月担任佛罗里达西南部部门的总裁,自1987年以来担任其他各种能力。


Charles J. Hall was appointed President - National Group in February 2011. Prior to that, Mr. Hall served as President - Eastern Group from October 2006 to February 2011. Mr. Hall had previously served the Company as President - North Florida Division from April 2003 until October 2006 as President of the East Florida Division from January 1999 until April 2003 as a Market President in the East Florida Division from January 1998 until December 1998 as President of the South Florida Division from February 1996 until December 1997 as President of the Southwest Florida Division from October 1994 until February 1996 and in various other capacities since 1987.
Charles J. Hall于2011年2月被任命为国家集团的总裁。在此之前,他从2006年10月到2011年2月担任东方集团的总裁。他之前从2003年4月到2006年10月担任公司北佛罗里达部门的总裁,从1999年1月到2003年4月担任东佛罗里达部门的总裁,从1998年1月到1998年12月担任东佛罗里达部门的市场总裁,从1996年2月到1997年12月担任南佛罗里达部门的总裁,从1994年10月到1996年2月担任佛罗里达西南部部门的总裁,自1987年以来担任其他各种能力。
Charles J. Hall was appointed President - National Group in February 2011. Prior to that, Mr. Hall served as President - Eastern Group from October 2006 to February 2011. Mr. Hall had previously served the Company as President - North Florida Division from April 2003 until October 2006 as President of the East Florida Division from January 1999 until April 2003 as a Market President in the East Florida Division from January 1998 until December 1998 as President of the South Florida Division from February 1996 until December 1997 as President of the Southwest Florida Division from October 1994 until February 1996 and in various other capacities since 1987.
Joseph A. Sowell, III

Joseph A. Sowell, III于2009年12月被任命为公司的高级副总裁兼首席发展官。从1987年到1996年,并从1999年到2009年,他是Waller Lansden Dortch & Davis律师事务所的合伙人,在此他专注于卫生保健领域的法律、合并和收购、合资企业、私人股本融资、税法和一般公司法。他还共同管理公司的企业和商业交易实践。从1996年到1999年他担任开发主管,后来成为Arcon Healthcare的首席运营官。


Joseph A. Sowell, III,was appointed as Senior Vice President and Chief Development Officer in December 2009. From 1987 to 1996 and again from 1999 to 2009, Mr. Sowell was a partner at the law firm of Waller Lansden Dortch & Davis where he specialized in the areas of health care law, mergers and acquisitions, joint ventures, private equity 32 financing, tax law and general corporate law. He also co-managed the firm's corporate and commercial transactions practice. From 1996 to 1999, Mr. Sowell served as the head of development, and later as the Chief Operating Officer of Arcon Healthcare.
Joseph A. Sowell, III于2009年12月被任命为公司的高级副总裁兼首席发展官。从1987年到1996年,并从1999年到2009年,他是Waller Lansden Dortch & Davis律师事务所的合伙人,在此他专注于卫生保健领域的法律、合并和收购、合资企业、私人股本融资、税法和一般公司法。他还共同管理公司的企业和商业交易实践。从1996年到1999年他担任开发主管,后来成为Arcon Healthcare的首席运营官。
Joseph A. Sowell, III,was appointed as Senior Vice President and Chief Development Officer in December 2009. From 1987 to 1996 and again from 1999 to 2009, Mr. Sowell was a partner at the law firm of Waller Lansden Dortch & Davis where he specialized in the areas of health care law, mergers and acquisitions, joint ventures, private equity 32 financing, tax law and general corporate law. He also co-managed the firm's corporate and commercial transactions practice. From 1996 to 1999, Mr. Sowell served as the head of development, and later as the Chief Operating Officer of Arcon Healthcare.
Jon M. Foster

Jon M. Foster于2013年1月被任命为美国集团的总裁。在此之前,他从2011年2月到2013年1月担任西南集团的总裁,从2006年1月至2011年2月担任中央和西德克萨斯部门的部门总裁。他于2001年3月加入HCA,担任位于德克萨斯州,奥斯汀的St. David's HealthCare的总裁兼首席执行官,担任该职位直到2011年2月。在加入该公司之前,他曾在田纳西州,诺克斯维尔的Baptist Health System和在德克萨斯州,休斯顿的The Methodist Hospital System担任各种行政能力。


Jon M. Foster,was appointed Executive Vice President and Chief Operating Officer effective January 1, 2023. Prior to that time, he served as President — American Group from January 2013 to December 2022, President — Southwest Group from February 2011 to January 2013 and Division President for the Central and West Texas Division from January 2006 to February 2011. Mr. Foster joined HCA in March 2001 as President and CEO of St. David's HealthCare in Austin, Texas and served in that position until February 2011. Prior to joining the Company, Mr. Foster served in various executive capacities within the Baptist Health System in Knoxville, Tennessee and The Methodist Hospital System in Houston, Texas.
Jon M. Foster于2013年1月被任命为美国集团的总裁。在此之前,他从2011年2月到2013年1月担任西南集团的总裁,从2006年1月至2011年2月担任中央和西德克萨斯部门的部门总裁。他于2001年3月加入HCA,担任位于德克萨斯州,奥斯汀的St. David's HealthCare的总裁兼首席执行官,担任该职位直到2011年2月。在加入该公司之前,他曾在田纳西州,诺克斯维尔的Baptist Health System和在德克萨斯州,休斯顿的The Methodist Hospital System担任各种行政能力。
Jon M. Foster,was appointed Executive Vice President and Chief Operating Officer effective January 1, 2023. Prior to that time, he served as President — American Group from January 2013 to December 2022, President — Southwest Group from February 2011 to January 2013 and Division President for the Central and West Texas Division from January 2006 to February 2011. Mr. Foster joined HCA in March 2001 as President and CEO of St. David's HealthCare in Austin, Texas and served in that position until February 2011. Prior to joining the Company, Mr. Foster served in various executive capacities within the Baptist Health System in Knoxville, Tennessee and The Methodist Hospital System in Houston, Texas.
P. Martin Paslick

P. Martin Paslick于2012年6月被任命为公司的高级副总裁兼首席信息官。之前,他从2010年3月到2012年5月担任信息技术与服务的副总裁兼首席运营官,从2006年9月到2010年2月担任信息技术和服务领域业务的副总裁。从1998年1月至2006年9月他在公司信息技术和服务部门担任各种副总裁角色。他于1985年加入公司。


P. Martin Paslick,was appointed Senior Vice President and Chief Information Officer in June 2012. Prior to that time, he served as Vice President and Chief Operating Officer of Information Technology & Services from March 2010 to May 2012 and Vice President — Information Technology & Services Field Operations from September 2006 to February 2010. From January 1998 to September 2006, he served in various Vice President roles in the Company's Information Technology & Services department. Mr. Paslick joined the Company in 1985.
P. Martin Paslick于2012年6月被任命为公司的高级副总裁兼首席信息官。之前,他从2010年3月到2012年5月担任信息技术与服务的副总裁兼首席运营官,从2006年9月到2010年2月担任信息技术和服务领域业务的副总裁。从1998年1月至2006年9月他在公司信息技术和服务部门担任各种副总裁角色。他于1985年加入公司。
P. Martin Paslick,was appointed Senior Vice President and Chief Information Officer in June 2012. Prior to that time, he served as Vice President and Chief Operating Officer of Information Technology & Services from March 2010 to May 2012 and Vice President — Information Technology & Services Field Operations from September 2006 to February 2010. From January 1998 to September 2006, he served in various Vice President roles in the Company's Information Technology & Services department. Mr. Paslick joined the Company in 1985.